Patent details

LUC00125 Product Name: Apremilast, or a pharmaceutically acceptable salt thereof

Basic Information

Publication number:
LUC00125
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP151771409
Legal Status:
Invalid
Application number:
LUC00125
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/14/981
Marketing Authorization Type:
Marketing Authorization Date:
16/01/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
14/06/2019
First Marketing Authorization date:
16/01/2015
Grant date:
24/12/2019
Activation date:
20/03/2023
Publication date:
18/06/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
20/03/2028
SPC Extension Expiration:
20/03/2028
Rejection date:
Withdrawal date:

Owner

From:
08/05/2020
 
 

Name:
Amgen (Europe) GmbH
Address:
Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)

History of Owners

From:
14/06/2019
To:
08/05/2020

Name:
Celgene Corporation
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Agent

Name:
Dennemeyer & Associates S.A.
From:
14/06/2019
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/08
Publication date:
10/07/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2020/01
Publication date:
13/01/2020
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
CO
Bulletin edition number:
2020/07
Publication date:
12/06/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

4

Bulletin Heading:
SPC3
Bulletin edition number:
2023/05
Publication date:
04/04/2023
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

5

Bulletin Heading:
VRV
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20200000144A
Date Registered:
08/05/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Amgen (Europe) GmbH
Address:
Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
18/02/2025
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
430 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
14/06/2019 General Document 2
25/05/2020 Outgoing Correspondence 2
14/06/2019 General Document 51
18/06/2019 Publication 1
14/06/2019 General Document 2
14/06/2019 General Document 4
14/06/2019 General Document 2
18/06/2019 Outgoing Correspondence 1
14/06/2019 Application Form 5
24/12/2019 Publication 1
24/12/2019 Certificate 1
08/05/2020 Request For Change 114
24/12/2019 Outgoing Correspondence 1